Relapsed or refractory (R/R) Acute lymphoblastic leukemia (ALL) research hub

A trial in patients with blood cancer and lymphatic system cancer looking at finding the optimal dose of BMF-219

This study is for adults with certain blood or lymphatic cancers that have come back or not responded to previous treatments. It's an early-stage trial looking at a new medicine called BMF-219 to find the safest and most effective dose for patients.